Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Genetics and Molecular Pathology SA Pathology Australia | 3 | 1 |
|
Invitae Connective Tissue Disorders Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 195 | 92 |
|
Invitae Skeletal Disorders Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 624 | 349 |
|
Invitae Limb and Digital Malformations Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 356 | 177 |
|
Labcorp Genetics (formerly Invitae) LabCorp United States | 57 | 27 |
|
Invitae Comprehensive Carrier Screen Labcorp Genetics (formerly Invitae) LabCorp United States | 886 | 547 |
|
Invitae Microphthalmia, Anophthalmia, Coloboma (MAC) and Anterior Segment Dysgenesis Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 130 | 81 |
|
Amsterdam UMC Genome Diagnostics Amsterdam University Medical Center Netherlands | 1 | 1 |
|
Fulgent Genetics United States | 49 | 15 |
|
Micromelic Dysplasia NGS Panel Fulgent Genetics United States | 140 | 24 |
|
Retinopathy and Optic Atrophy NGS Panel Fulgent Genetics United States | 563 | 241 |
|
Microphthalmia, Anophthalmia, and Coloboma Panel NGS Panel Fulgent Genetics United States | 244 | 78 |
|
Beacon Expanded Female Carrier Screening Plus Panel Fulgent Genetics United States | 716 | 335 |
|
Beacon Expanded Male Carrier Screening Panel Fulgent Genetics United States | 636 | 298 |
|
Beacon Expanded Male Carrier Screening Plus Panel Fulgent Genetics United States | 661 | 306 |
|
Beacon Expanded Female Carrier Screening Panel Fulgent Genetics United States | 690 | 326 |
|
Primary Congenital Glaucoma: gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 1 | 3 |
|
Eye diseases comprehensive panel Asper Biogene Asper Biogene LLC Estonia | 367 | 291 |
|
Primary congenital glaucoma 3A Bioarray Spain | 1 | 1 |
|
Developmental Eye Disease panel Molecular Vision Laboratory United States | 107 | 59 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.